Australia markets closed

WuXi Biologics (Cayman) Inc. (WXXWY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
3.2400+0.0500 (+1.57%)
At close: 03:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
16,554,266
15,268,660
10,290,050
5,612,384
Cost of revenue
9,682,825
8,544,646
5,461,153
3,079,418
Gross profit
6,871,441
6,724,014
4,828,897
2,532,966
Operating expenses
Research development
753,130
682,818
501,583
303,734
Selling general and administrative
1,630,323
1,432,505
1,000,579
605,851
Total operating expenses
2,177,492
1,925,659
1,364,232
771,431
Operating income or loss
4,693,949
4,798,355
3,464,665
1,761,535
Interest expense
120,540
64,382
39,191
42,732
Income before tax
4,956,612
5,357,771
3,993,119
1,965,760
Income tax expense
690,071
807,865
484,538
273,066
Income from continuing operations
4,266,541
4,549,906
3,508,581
1,692,694
Net income
4,151,897
4,420,286
3,388,478
1,688,886
Net income available to common shareholders
4,151,897
4,420,286
3,388,478
1,688,886
Basic EPS
2.00
2.12
1.62
0.86
Diluted EPS
1.90
2.02
1.54
0.80
Basic average shares
2,081,944
2,086,368
2,086,841
1,976,482
Diluted average shares
2,178,831
2,187,954
2,210,898
2,104,585